News
Analysts are estimating that Xenon Pharmaceuticals will report an earnings per share (EPS) of $-1.00. Anticipation surrounds Xenon Pharmaceuticals's announcement, with investors hoping to hear about ...
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Sherry Aulin - CFO Ian Mortimer - President and CEO Dr. Chris Kenney - CMO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback